SyntekaBio Enters ‘Assetization Phase’ for AI Asset Program 송영두 2026.01.21 오전 09:27 Syntekabio wins SI deal from HYBE’s Weverse unit 나은경 2025.12.17 오후 01:42 SyntekaBio Licenses Out Five AI-Designed Multispecific Antibodies to Panolos 송영두 2025.12.16 오후 04:33 ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 김새미 2025.11.12 오후 06:05 Syntekabio Leads AI Datacenter Shift with Eco-Friendly Natural Convection 송영두 2025.07.21 오전 10:26 Syntekabio Showcases AI Drug Platform at Interbiz 2025 송영두 2025.07.07 오후 02:53 Syntekabio Expands Global Contracts, Boosts Growth with Next-Gen AI Platforms 송영두 2025.08.27 오후 05:34 SyntekaBio, Panolos Sign MOU on Next-Gen Multispecific Antibodies 송영두 2025.12.05 오전 09:55 Peptron Jumps on Lilly Hopes; CORESTEMCHEMON Falls on Rights Issue[K-Bio Pulse] 김새미 2025.11.21 오전 08:50 Syntekabio Unveils ‘Super-Gap’ Collaboration Model at APEC Event 송영두 2025.10.29 오후 05:13 더 보기 로딩중..
Syntekabio
Syntekabio
![ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25111201284b.jpg)
![Peptron Jumps on Lilly Hopes; CORESTEMCHEMON Falls on Rights Issue[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25112100378b.jpg)
